Artificial intelligence (AI) can predict how well patients with rectal cancer will respond to treatment by analysing standard tissue samples taken during diagnosis, finds a new study from researchers at UCL and UCLH. In most cancers, the immune landscape surrounding a tumour plays a major role in determining how cancer progresses and how patients respond to therapy, yet the complex interactions between immune cells, tumour cells, and treatment often remain poorly understood. The new study,